(Q42992261)

12 November 2017

Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

1 reference

8

1 reference

12 November 2017

Fanning L

1

1 reference

12 November 2017

Kenny E

2

1 reference

12 November 2017

Sheehan M

3

1 reference

12 November 2017

Cannon B

4

1 reference

12 November 2017

Whelton M

5

1 reference

12 November 2017

O'Connell J

6

1 reference

12 November 2017

Collins JK

7

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

12 November 2017

1 reference

12 November 2017

29

1 reference

12 November 2017

904-907

1 reference

12 November 2017

3

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Epidemiology of hepatitis C in the West

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Transmission of hepatitis C virus--route, dose, and titer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Hepatitis C virus six years on.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Transmission of viral infections through intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Hepatitis C virus genotypes are not responsible for development of serious liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Relationship of genotype to level of hepatitis C viraemia determined by competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Hepatitis C viraemia in recipients of Irish intravenous anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

ABC of alcohol. Definitions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Alanine aminotransferase measurements and histological disease in hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290310

7 January 2021

Identifiers

DOI

10.1002/HEP.510290310

1 reference

12 November 2017

1 reference